The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, some analysts have warned.
Section 340B of the Public Health Service Act requires drug manufacturers participating in Medicaid to provide outpatient drugs at discounted prices to eligible healthcare organizations that serve large amounts of uninsured and low-income patients, according to an American Hospital Association (AHA) fact sheet. The program also allows eligible entities to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services,” per the Health Resources and Services Administration. (RELATED: EXCLUSIVE: Conservative Group Drops Ad Warning Program Could Subsidize Health Care For Illegal Immigrants)
While proponents of the 340B program have touted its potential benefits such as rural…




